An AMP result on a drug test flags the presence of amphetamine or a substance the test interprets as structurally similar to amphetamine. That includes prescription stimulants like Adderall and Vyvanse, illicit methamphetamine and MDMA, and a surprisingly long list of medications and over-the-counter products that have nothing to do with stimulant use. The gap between what the initial screen catches and what you actually took is wide enough that workplace drug-testing programs require a second, more specific test before anyone faces consequences.
What the AMP Screen Actually Detects
Standard drug-test panels include an amphetamines category, often abbreviated AMP or AMP/MAMP. The initial screening step uses an immunoassay, which works by measuring how well molecules in your urine bind to antibodies designed to recognize amphetamine and methamphetamine. If binding crosses a preset threshold, the sample screens positive. The problem is that those antibodies are not perfectly selective. Any molecule shaped enough like amphetamine or methamphetamine can latch onto them and push the reading over the line.
Different immunoassay platforms have different blind spots. Research comparing six commercial immunoassays found that the panel of drugs each one flagged varied, with cutoffs and cross-reactivity profiles differing by manufacturer.1Journal of Analytical Toxicology. Comparison of the Sensitivity and Specificity of Six Immunoassays for the Detection of Amphetamines in Urine Predictive modeling of cross-reactivity has shown that for some assays, molecular similarity to both amphetamine and MDMA together best predicts whether a substance will trigger a positive, while for other assays, three-dimensional shape matching matters more.2PubMed. Cross-reactivity studies and predictive modeling of “Bath Salts” and other amphetamine-type stimulants with amphetamine screening immunoassays In plain terms, each brand of test has its own personality when it comes to what it mistakes for amphetamine.
Prescription Stimulants
The most straightforward cause of an AMP-positive result is a prescription amphetamine. Adderall (mixed amphetamine salts), dextroamphetamine, and lisdexamfetamine (Vyvanse) all produce amphetamine in the body and will register on any properly functioning screen. This is a true positive, not a false alarm. After a single therapeutic dose of dexamphetamine or lisdexamfetamine, amphetamine remains detectable in urine for a median of roughly 77 to 78 hours, or about three days.3PubMed Central. Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers
Adderall also contains trace amounts of methamphetamine as a pharmaceutical impurity. Lab analysis has found methamphetamine concentrations around 4.6 ng/mL in dissolved Adderall XR at a ratio of roughly 0.003% relative to the amphetamine content.4Journal of Mass Spectrometry and Advances in the Clinical Lab. Urine methamphetamine-to-amphetamine ratio by LC-MS/MS to differentiate methamphetamine use from pharmaceutical impurity in patients prescribed amphetamine That trace amount is far too small to cause a positive methamphetamine confirmation on its own, but it matters for labs trying to distinguish prescribed amphetamine from illicit methamphetamine use. When the ratio of methamphetamine to amphetamine in a urine sample is extremely low, it points to a legitimate prescription rather than street methamphetamine.
Over-the-Counter Nasal Decongestants
Vicks VapoInhaler is one of the most well-documented causes of a false-positive AMP screen. It contains levmetamfetamine (also written l-methamphetamine), which is the mirror-image form of the illicit drug. The l-form has almost no stimulant effect and is sold legally, but standard immunoassays cannot tell the two mirror forms apart. In a controlled study, the EMIT II Plus assay produced false-positive results in about 2% of urine specimens after legitimate Vicks VapoInhaler use.5PubMed Central. Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration Oral fluid testing is even more vulnerable: positive methamphetamine results appeared after as few as one to four doses at the manufacturer-recommended rate.6PubMed Central. Oral Fluid with Three Modes of Collection and Plasma Methamphetamine and Amphetamine Enantiomer Concentrations After Controlled Intranasal l-Methamphetamine Administration
Pseudoephedrine, found in Sudafed and many cold formulas, is another decongestant that has been reported to trigger AMP false positives on certain immunoassay platforms.7PubMed Central. Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine The risk is generally lower than with Vicks VapoInhaler, but anyone facing a drug test should be aware it can happen.
Prescription Medications That Cross-React
A number of commonly prescribed drugs that have no stimulant properties can still trip the AMP screen. The best-studied offender is bupropion (sold as Wellbutrin for depression and as Zyban for smoking cessation). In one hospital study, 41% of amphetamine-positive screens that failed to confirm on more specific testing were traced back to patients taking bupropion, making it the single most frequent cause of false positives in that population.8PubMed Central. Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay
Promethazine (Phenergan), an anti-nausea medication in the phenothiazine family, is another frequent culprit. Thirty-six percent of patients taking promethazine had false-positive urine amphetamine results using one widely used immunoassay.9PubMed. Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays A broader review of the literature identified false-positive amphetamine or methamphetamine results associated with a wide range of medications, including trazodone, venlafaxine (Effexor), sertraline (Zoloft), quetiapine (Seroquel), chlorpromazine, ranitidine, dextromethorphan, and diphenhydramine (Benadryl), among others.10American Journal of Health-System Pharmacy. Commonly prescribed medications and potential false-positive urine drug screens
The unifying theme is structural. All of these drugs share some molecular features with amphetamine, enough to fool an antibody that is casting a deliberately wide net. The immunoassay is designed to be sensitive rather than specific, because the philosophy of the first-pass screen is to catch everything and sort it out later with a confirmatory test.
Weight Loss Drugs and Phentermine
Phentermine (sold alone or in the combination drug Qsymia) is a stimulant appetite suppressant that belongs to the same chemical family as amphetamine. It will almost always trigger a positive AMP screen. Because phentermine is so structurally close to amphetamine, it creates problems even during the confirmatory step. Research from Department of Defense drug-testing programs found that phentermine interferes with the chromatography used in one standard confirmation method, skewing the measured concentration of d-amphetamine and potentially leading to inaccurate results.11PubMed. Phentermine interference and high L-methamphetamine concentration problems in GC-EI-MS SIM Analyses of R-(-)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride-derivatized amphetamines and methamphetamines Labs that know to look for phentermine can resolve this, but the interference is another reason why anyone taking a weight-loss medication should disclose it before a drug test.
Selegiline and Prodrugs That Become Amphetamine in the Body
Some medications are not amphetamines themselves but are converted to amphetamine or methamphetamine through normal metabolism. Selegiline (Eldepryl, Emsam) is the most common example. It is prescribed for Parkinson’s disease and, in patch form, for depression. In the body, selegiline breaks down into l-methamphetamine and l-amphetamine, producing a characteristic metabolic pattern with a methamphetamine-to-amphetamine ratio of roughly 2.8.12PubMed. Methamphetamine and amphetamine derived from the metabolism of selegiline This means a selegiline user will test positive for both methamphetamine and amphetamine on a standard screen, even though they have never touched an illicit drug. The l-form produced from selegiline can be distinguished from the d-form associated with illicit use through chiral analysis, but that additional testing step has to be specifically requested.
MDMA and Other Illicit Amphetamine-Type Stimulants
MDMA (ecstasy/molly), MDA, and other ring-substituted amphetamines reliably trigger the AMP immunoassay. Studies of cross-reactivity found that MDA, MDMA, and ethylamphetamine showed cross-reactivities in the range of 30 to 250% on assays targeting amphetamine or methamphetamine, meaning they can actually produce a stronger signal than amphetamine itself at equivalent concentrations.13PubMed. Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays Synthetic cathinones (the so-called “bath salts”), by contrast, generally showed less than 4% cross-reactivity on amphetamine or methamphetamine assays, so most of them will not show up as AMP on a standard screen.
How the Confirmation Step Sorts It Out
A positive immunoassay screen is never the final word in regulated testing. The sample goes through a confirmation analysis, typically using gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods identify specific molecules by their mass and fragmentation pattern, so they can distinguish amphetamine from bupropion or promethazine with high accuracy. If the confirmatory test does not find actual amphetamine or methamphetamine above the cutoff, the result is reported as negative regardless of what the initial screen said.
When methamphetamine is confirmed, the next question is often whether it is the d-isomer (associated with illicit use) or the l-isomer (found in Vicks VapoInhaler and selegiline). This requires chiral separation, a specialized step that many labs can perform. LC-MS/MS-based chiral methods have proven more accurate than the older GC-MS derivatization approach, which showed error rates of 8 to 19% in determining which isomer was present. The LC-MS/MS method brings that error below 2%.14Journal of Analytical Toxicology. Improved Chiral Separation of Methamphetamine Enantiomers Using CSP-LC–MS-MS That distinction matters enormously, because a result showing only the l-isomer supports a medical explanation while the d-isomer points toward illicit methamphetamine.
What Happens After a Positive Result at Work
In regulated workplace testing programs, a positive confirmed result does not go straight to the employer. It first passes through a Medical Review Officer, a physician trained to evaluate whether the result has a legitimate medical explanation. If you have a valid prescription for Adderall, or your doctor prescribed selegiline, or you can document phentermine use, the MRO can verify the result as negative before it reaches your employer.15PubMed Central. The role of physicians as medical review officers in workplace drug testing programs. In pursuit of the last nanogram.
The MRO process catches a lot. In one large workplace testing dataset, 63% of confirmed amphetamine-positive samples were verified by the MRO as due to medical prescription and reported as negative.16PubMed Central. Workplace Drug Testing-Prevalence of Positive Test Results, Most Common Substances, and Importance of Medical Review That means nearly two out of every three confirmed amphetamine positives in the workplace had a legal explanation. The practical advice is straightforward: bring documentation of any prescription or OTC medication that could affect your test, and bring it before you are tested if possible.
Cutoff Levels and Why They Matter
The cutoff concentration determines how much amphetamine must be present in a sample before the test calls it positive. For federally regulated workplace testing in the United States, the standard immunoassay screening cutoff for amphetamines has traditionally been 1,000 ng/mL, with a confirmation cutoff of 500 ng/mL for methamphetamine and 200 ng/mL for amphetamine. Research has shown that the 1,000 ng/mL screening cutoff is too high to consistently detect a single 5-mg oral dose of d-amphetamine.17PubMed. Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing Lower cutoffs of 250 ng/mL for methamphetamine and 100 ng/mL for amphetamine have been proposed and studied. Dropping to these levels extended detection time by up to 34 hours and increased the total number of positive specimens by 48%.18Clinical Chemistry. Duration of Detectable Methamphetamine and Amphetamine Excretion in Urine after Controlled Oral Administration of Methamphetamine to Humans
Lower cutoffs improve the ability to detect actual drug use, but they also increase the chance of flagging trace amounts from legitimate sources. That tradeoff is part of why cutoff changes move slowly through the regulatory process.
How Urine pH and Hydration Affect Results
Amphetamine is excreted faster when urine is acidic and when urine flow is high.19Journal of Analytical Toxicology. Urinary Excretion of d-Amphetamine Following Oral Doses in Humans: Implications for Urine Drug Testing Someone who is well hydrated and has acidic urine will clear amphetamine faster, which paradoxically makes detection easier in the short window after use because more of the drug is being flushed into the urine at once, while also shortening the total window of detectability. Conversely, alkaline urine slows excretion, which can extend the detection window but lower the peak concentration in any single sample. These are real physiological variables, not urban-legend cheats. They help explain why detection times in published studies vary so widely from person to person.
Point-of-Care Tests and Rapid Screening Devices
Rapid cup tests, dipstick tests, and other point-of-care devices are immunoassay-based, just like the lab screens, but they tend to be less precise. A field evaluation of five on-site drug-testing devices found false-positive rates for amphetamines of up to about 4% when the confirmation battery was limited to the standard analytes, and rates of 1.75% or below when the confirmation battery was expanded to include MDMA and other sympathomimetic amines.20Journal of Analytical Toxicology. A Field Evaluation of Five On-Site Drug-Testing Devices If you receive a positive AMP result on a rapid test in an urgent care clinic, an emergency room, or an employer’s parking lot, that result is a preliminary finding. It does not definitively mean amphetamine is present.
Oral Fluid Testing and Detection Windows
Urine remains the most common sample type for drug testing, but oral fluid (saliva) testing is increasingly used, especially in roadside and workplace settings. Detection windows for amphetamine are broadly comparable between the two. After a single therapeutic dose, amphetamine was detectable in oral fluid for a median of 67 to 69 hours and in urine for 77 to 78 hours, with a high probability of detection for at least 24 hours after ingestion.3PubMed Central. Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers Under different conditions and higher exposures, oral fluid detection windows for amphetamine and methamphetamine have been reported at up to eight days, longer than corresponding urine windows at the cutoffs used in that study.21PubMed. Extended Detection of Amphetamine and Methamphetamine in Oral Fluid
Oral fluid testing has its own false-positive vulnerabilities. The Vicks VapoInhaler issue is actually worse with saliva, since the l-methamphetamine is inhaled through the nasal passages and some of it ends up in oral secretions, producing detectable methamphetamine after just a handful of doses. Chiral confirmatory analysis eliminates these false positives, but only if the testing program includes that step.6PubMed Central. Oral Fluid with Three Modes of Collection and Plasma Methamphetamine and Amphetamine Enantiomer Concentrations After Controlled Intranasal l-Methamphetamine Administration
Sample Adulteration
Some people attempt to beat a drug test by adding substances to their urine sample. Research has tested common household chemicals as adulterants, including bleach, drain cleaner, vinegar, and sodium nitrite. Four of these produced false-negative results for amphetamine and other drugs on ELISA screening at concentrations as low as roughly 5% by volume.22PubMed. Determining the effects of adulterants on drug detection via enzyme-linked immunosorbent assay and adulterant tests strips However, regulated testing programs include specimen-validity checks that measure pH, temperature, creatinine, and specific gravity. Samples that are too dilute, too acidic, too basic, or abnormally warm will be flagged as invalid or substituted, triggering a retest under observed conditions. Adulteration is easy to detect in a properly run program and typically treated as refusal to test.
Methylphenidate and Other Stimulants That Do Not Show Up as AMP
Not every stimulant registers on the amphetamine screen. Methylphenidate (Ritalin, Concerta) is a completely different molecule that does not cross-react with amphetamine immunoassays. It has its own detection profile and its own metabolite, ritalinic acid, but neither of these will produce an AMP-positive result. After a single dose, methylphenidate is detectable in oral fluid for about 36 hours and in urine (as ritalinic acid) for about 41 hours.3PubMed Central. Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers Standard workplace panels do not test for it at all, though expanded clinical panels sometimes do. Similarly, caffeine, modafinil, and atomoxetine are stimulant or stimulant-adjacent medications that generally do not trigger the AMP screen, though atomoxetine has been reported to cause false positives on at least some immunoassay platforms.7PubMed Central. Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
Quick Reference of Common AMP Triggers
To make this practical, here is a consolidated list of the substances most commonly reported to produce an AMP-positive screen, grouped by source:
- Prescription amphetamines: Adderall, dextroamphetamine, lisdexamfetamine (Vyvanse), methamphetamine (Desoxyn). These are true positives.
- Prodrugs: Selegiline metabolizes into l-methamphetamine and l-amphetamine.
- Weight loss drugs: Phentermine (Adipex-P, Qsymia).
- OTC decongestants: Vicks VapoInhaler (l-methamphetamine), pseudoephedrine products.
- Antidepressants: Bupropion (Wellbutrin/Zyban), trazodone, sertraline, venlafaxine.
- Antipsychotics and antihistamines: Promethazine, chlorpromazine, quetiapine, diphenhydramine.
- Illicit drugs: Methamphetamine, MDMA, MDA.
A positive initial screen from any of these does not mean you will face consequences. The confirmation test will separate the true amphetamine signal from the noise, and the MRO review will account for legitimate prescriptions. The system has real safeguards built in, but those safeguards depend on you disclosing your medications and cooperating with the review process.